US Patent 11242349 Ethynyl derivatives
All edits
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+227 characters)
Article
Patent abstract
The present invention relates to compounds that may be used in the treatment of Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression or diabetes type 2.
Edits on 15 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Antonio Ricci0
Barbara Biemans0
Daniel Rueher0
Fionn O'Hara0
Georg Jaeschke0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
112423490
Date of Patent
February 8, 2022
0Patent Application Number
168652330
Date Filed
May 1, 2020
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11242349 Ethynyl derivatives
Infobox
Is a
Patent jurisdiction
Patent number
11242349
Date of patent
February 8, 2022
Patent application number
16865233
Date Filed
May 1, 2020
Patent primary examiner
Find more entities like US Patent 11242349 Ethynyl derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
